Detection of moderate and severe coronary artery stenosis with technetium-99m tetrofosmin myocardial single-photon emission tomography

European Journal of Nuclear Medicine

Volumn 24, Issue 10, 1997, Pages 1230-1236

  Sacchetti, Gianmauro ^a   Inglese, Eugenio ^a   Bongo, Angelo S ^a   Aina, Franco ^a   Brambilla, Marco ^a   Baroli, Alberto ^a   Cernigliaro, Carmelo ^a   Dellavesa, Pierfranco ^a   Pittaluga, Edgardo ^a   Rudoni, Marco ^a  

^a MAGGIORE DELLA CARITÀ HOSPITAL   (Italy)

Author keywords

Coronary artery stenosis; Myocardial perfusion; Single photon emission tomography; Technetium 99 tetrofosmin

Indexed keywords

RADIOPHARMACEUTICAL AGENT; TETROFOSMIN TC 99M;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CORONARY ARTERY CIRCUMFLEX BRANCH; CORONARY ARTERY OBSTRUCTION; DIAGNOSTIC ACCURACY; FEMALE; HEART SCINTISCANNING; HUMAN; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MAJOR CLINICAL STUDY; MALE; RIGHT CORONARY ARTERY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

CORONARY ANGIOGRAPHY; CORONARY DISEASE; EXERCISE TEST; FEMALE; HEART; HUMANS; MALE; MIDDLE AGED; ORGANOPHOSPHORUS COMPOUNDS; ORGANOTECHNETIUM COMPOUNDS; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 9844250208     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590050146     Document Type: Article

References (23)

1. Nakajima K, Taki J, Shuke N, et al. Myocardial perfusion imaging and dynamic analysis with technetium-99m tetrofosmin. J Nucl Med 1993; 34: 1478-1484.
2. Sullo P, Cuocolo A, Nicolai E, et al. Quantitative exercise technetium-99m-tetrofosmin myocardial tomography for the identification and localization of coronary artery disease. Eur J Nucl Med 1996; 23: 648-655.
3. Heo J, Cave V, Wasserleben V, Iskandrian A. Planar and tomographic imaging with technetium-99m labeled tetrofosmin: correlation with thallium-201 and coronary angiography. J Nucl Cardiol 1994; 1: 317-324.
4. Sridhara B, Sochor H, Rigo P, et al. Myocardial single photon emission computed tomographic imaging with technetium-99m tetrofosmin: stress-rest imaging with same-day and separate-day rest imaging. J Nucl Cardiol 1994; 1: 138-143.
5. Montz R, Perez-Castejon MJ, Jurado JA, et al. Technetium-99m-tetrofosmin rest/stress myocardial SPET with a same-day 2-hour protocol: comparison with coronary angiography. Eur J Nucl Med 1996; 23: 639-647.
6. Tamaki N, Takahashi N, Kawamoto M, et al. Myocardial tomography using technetium-99m-tetrofosmin to evaluate coronary artery disease. J Nucl Med 1994; 35: 594-600.
7. 99mTc-tetrofosmin as a myocardial perfusion agent in routine clinical use. Nucl Med Commun 1995; 16: 733-740.
8. Mock MB, Rinquist I, Fischer LD, et al. Survival of medically treated patients in the Coronary Artery Surgery Study (CASS) registry. Circulation 1982; 66: 562-568.
9. Streiner DL, Norman GR. Health measurement scales. New York: Oxford University Press, 1991.
10. Wiener BJ. Statistical principles in experimental design. New York: McGraw-Hill, 1971.
11. Hendel RC, Parker MA, Wackers FJT, et al. Reduced variability of interpretation and improved image quality with a technetium 99m myocardial perfusion agent: comparison of thallium-201 and technetium-99m-labeled tetrofosmin. J Nucl Cardiol 1994; 1: 509-514.
12. Kiat H, Maddahi J, Roy LT, et al. Comparison of Tc-99m methoxyisobutylisonitrile with thallium-201 for evaluation of coronary artery disease by planar and tomographic methods. Am Heart J 1989; 117: 1-11.
13. m-sestamibi: comparison of dipyridamole versus exercise and of planar versus tomographic imaging. Nucl Med Commun 1993; 14: 946-954.
14. Mahmood S, Gunning M, Bomanji JB, et al. Combined rest thallium-201/stress technetium-99m-tetrofosmin SPECT: feasibility and diagnostic accuracy of a 90 minute protocol. J Nucl Med 1995; 36: 932-935.
15. 201Tl imaging and coronary angiography in a phase III multicenter trial. Circulation 1995; 91: 313-319.
16. He Z, Iskandrian AS, Gupta NC, Verani M. Assessing coronary artery disease with dipyridamole technetium-99m-tetrotbsmin SPECT: a multicenter trial. J Nucl Med 1997; 38: 44-48.
17. Petitti DB. Meta-analysis, decision analysis and cost-effectiveness analysis. New York: Oxford University Press, 1994.
18. Gould KL, Kelley KO. Experimental validation of quantitative coronary arteriography for determining pressure-flow characteristics of coronary stenosis. Circulation 1982; 66: 930-937.
19. Marcus ML, Skorton DJ, Johnson MR, et al. Visual estimates of percent diameter coronary stenosis: "a battered gold standard". J Am Coll Cardiol 1988; 11: 882-888.
20. Dilsizian V, Rocco TP, Strauss HW, Boucher CA. Technetium-99m isonitrile myocardial uptake at rest. I. Relation to severity of coronary artery stenosis. J Am Coll Cardiol 1989; 14: 1673-1677
21. Rocco TP, Dilsizian V, McKusick KA, et al. Comparison of thallium redistribution with rest "reinjection" imaging for the detection of viable myocardium. Am J Coll Cardiol 1990; 66: 158-163.
22. Cuocolo A, Soricelli A, Nicolai E, et al. Technetium-99m-tetrofosmin regional myocardial uptake at rest: relation to severity of coronary artery setnosis in previous myocardial infarclion. J Nucl Med 1995; 36: 907-913.
23. Au Yong TK, Chambers J, Maisley MN, et al. Technetuim-99m tetrofosmin myocardial perfusion scan: comparison of 1-day and 2-day protocols. Eur J Nucl Med 1996; 23: 320-325.